(Total Views: 611)
Posted On: 05/01/2020 11:15:12 AM
Post# of 154145
Re: nmbr1stckpckr #31173
Nmbr1stckpckr,
Yes, in the context of investing this is a typical example of market ineficiency.
The news of Remdesivir have been circulation all over the world as the arrival of the savior where the results are, shall I say, lacking?
Yet, the big news, that CHARACTERIZATION of COVID and, henceforth, the beginning of the solution, has achieved a complete yawn …
If markets where efficient CYDY would had jumped tree days ago, when the first hints of Drs. Lalezari and Patterson regarding the discovery of the extreme up-regulation of RANTES.
Who loses? Those who ignore the science. Who benefits ?? Well, me, as I was able to buy this morning more shares at a vey good price. And you all longs.
At the end, when the numbers come out the whole world will smell the coffee when is pass breakfast time … We will be whistling to the bank.
Quote:
I'm surprised that COVID-19 being a rantes disease hasn't made it to any news outlets yet.
Yes, in the context of investing this is a typical example of market ineficiency.
The news of Remdesivir have been circulation all over the world as the arrival of the savior where the results are, shall I say, lacking?
Yet, the big news, that CHARACTERIZATION of COVID and, henceforth, the beginning of the solution, has achieved a complete yawn …
If markets where efficient CYDY would had jumped tree days ago, when the first hints of Drs. Lalezari and Patterson regarding the discovery of the extreme up-regulation of RANTES.
Who loses? Those who ignore the science. Who benefits ?? Well, me, as I was able to buy this morning more shares at a vey good price. And you all longs.
At the end, when the numbers come out the whole world will smell the coffee when is pass breakfast time … We will be whistling to the bank.
(2)
(0)
